Catapult Ventures

Catapult Ventures, established in 1999, is a UK-based independent asset management firm headquartered in Leicester. With a team boasting over a decade of collective experience in venture capital, the firm specializes in early-stage investments, primarily in technology, life sciences, and healthcare sectors across the United Kingdom. Their expertise spans various stages of company growth, from start-ups to established businesses, and across diverse industries such as healthcare, luxury consumer brands, manufacturing, and software.

Duncan Cameron

CFO

Rob Carroll

Director

Vijay Curthan

Investment Director

Chris Spencer

Venture Partner, Catapult's GM&C Life Sciences Fund

Laurence Vaughan

Chairman

Nick Wright

CEO

105 past transactions

Pickle Robot

Series B in 2024
Pickle Robot Company, founded in 2018 and headquartered in Cambridge, Massachusetts, specializes in the development of a package-handling robot designed to streamline operations within the e-commerce supply chain. The company's flagship robot, Dill, addresses the challenges of a labor-intensive industry characterized by high turnover rates and rising shipping costs, which are primarily driven by labor expenses. Dill automates essential functions such as loading and unloading feeder trucks, palletizing and depalletizing mixed parcels, preloading last-mile delivery vehicles, and sorting packages. By enhancing efficiency and reducing labor costs, Pickle Robot aims to alleviate bottlenecks in logistics, enabling e-commerce companies to improve their operational workflows and support continued growth in the sector.

Path Robotics

Series D in 2024
Path Robotics, Inc. is a Cleveland-based company established in 2018, specializing in the manufacture of autonomous welding robots. The company designs advanced robotic welding systems that utilize artificial intelligence and machine learning to enhance precision and adaptability in manufacturing processes. These systems automate repetitive tasks, significantly increasing productivity while reducing upfront costs for manufacturers. By addressing workforce challenges in the manufacturing sector, Path Robotics offers solutions that simplify production, improve testing and tolerances, and reduce inconsistencies that can lead to errors or waste. Their robots autonomously locate and weld seams, while also verifying parts and generating tool paths for each component introduced, thereby streamlining the overall production process.

CroBio

Seed Round in 2024
CroBio Ltd is an agricultural biotechnology company that focuses on developing innovative solutions to enhance water retention in soil, particularly in the face of global agricultural drought. Founded in 2019 and based in Macclesfield, United Kingdom, the company specializes in genetically engineered root-associated bacteria that create a self-sustaining, biologically active material capable of improving soil health. By harnessing expertise in microbiology and engineering, CroBio aims to provide environmentally sustainable solutions that address the challenges of water scarcity in agriculture.

Pencil Biosciences

Seed Round in 2023
Pencil Biosciences is focused on advancing gene-editing technology through the development of a novel, programmable genome-modulation platform. This innovative approach seeks to address the limitations of existing gene-editing technologies, providing new therapeutic options for patients with rare diseases. By enhancing the precision and efficacy of genome modulation, Pencil Biosciences aims to facilitate a wide range of applications in the medical field, ultimately supporting healthcare professionals in overcoming the challenges associated with traditional gene-editing methods.

QV Bioelectronics

Seed Round in 2023
QV Bioelectronics is focused on improving the lives of brain tumor patients through its innovative electric field therapy implant, GRACE. Developed in collaboration with leading neurosurgeons in the UK, GRACE aims to enhance life expectancy for patients suffering from glioblastoma, a brain tumor known for its poor prognosis and limited treatment options. Recognizing the significant gaps in effective therapies, co-founder Dr. Richard Fu, an academic neurosurgeon, teamed up with biomedical engineer Dr. Chris Bullock to address design flaws in existing electric field therapies. Their solution leverages advanced materials science, including the use of graphene, to optimize device performance and patient outcomes. Since its inception, QV Bioelectronics has garnered nearly $1 million in funding from various UK institutions and over $1 million from international life science investors. The company operates from its research hub in Alderley Park, Cheshire, and boasts a multidisciplinary team with extensive experience in bringing innovative medical devices to the clinic.

Urban Machine

Seed Round in 2022
Urban Machine is a construction company focused on the reclamation and manufacturing of premium lumber products from wood waste. It specializes in removing nails, screws, and staples from reclaimed wood sourced from demolition sites and construction waste. By utilizing advanced robotics and artificial intelligence, Urban Machine efficiently salvages lumber that can be transformed into high-quality products, offering a sustainable alternative to virgin lumber. The company's mission is to contribute to a more sustainable future by reducing waste in the construction industry and minimizing its environmental impact.

Pickle Robot

Series A in 2022
Pickle Robot Company, founded in 2018 and headquartered in Cambridge, Massachusetts, specializes in the development of a package-handling robot designed to streamline operations within the e-commerce supply chain. The company's flagship robot, Dill, addresses the challenges of a labor-intensive industry characterized by high turnover rates and rising shipping costs, which are primarily driven by labor expenses. Dill automates essential functions such as loading and unloading feeder trucks, palletizing and depalletizing mixed parcels, preloading last-mile delivery vehicles, and sorting packages. By enhancing efficiency and reducing labor costs, Pickle Robot aims to alleviate bottlenecks in logistics, enabling e-commerce companies to improve their operational workflows and support continued growth in the sector.

Strella Biotechnology

Series A in 2022
Strella Biotechnology, founded in 2018 and headquartered in Philadelphia, Pennsylvania, focuses on enhancing the freshness of produce throughout the supply chain. The company specializes in designing and manufacturing sensors that detect ethylene gas, a key indicator of ripeness in fruits. By measuring ethylene production, Strella's technology helps optimize freshness and minimize spoilage. The company leverages its proprietary sensing technology to provide valuable data for improving supply chain management in the food industry.

Urban Machine

Pre Seed Round in 2021
Urban Machine is a construction company focused on the reclamation and manufacturing of premium lumber products from wood waste. It specializes in removing nails, screws, and staples from reclaimed wood sourced from demolition sites and construction waste. By utilizing advanced robotics and artificial intelligence, Urban Machine efficiently salvages lumber that can be transformed into high-quality products, offering a sustainable alternative to virgin lumber. The company's mission is to contribute to a more sustainable future by reducing waste in the construction industry and minimizing its environmental impact.

Viscgo

Venture Round in 2021
Viscgo Limited is a company that specializes in the design, development, and delivery of innovative devices and technologies aimed at improving the management of dysphagia, a swallowing disorder. Founded in 2015 and based in Warrington, United Kingdom, Viscgo's product offerings include drink thickness testers that measure the viscosity of various drinks and textured-modified foods. Their technology enables caregivers and healthcare professionals in hospitals, care homes, schools, and nurseries to provide smooth fluids to patients with dysphagia, thereby enhancing their care and quality of life.

Maxwellia

Venture Round in 2021
Maxwellia Ltd is a company focused on converting prescription medicines into over-the-counter (OTC) products, allowing individuals to manage their health without physician intervention. Established in 2013 and based in Alderley Edge, United Kingdom, Maxwellia specializes in a process known as "switching," which repurposes established prescription drugs into accessible consumer brands. The company offers a comprehensive suite of services, including SwitchScreen, which identifies potential drug candidates; SwitchUp, which designs the switching process and evaluates market opportunities; and SwitchAbility, which supports the entire journey from concept to market launch. Through its innovative approach, Maxwellia aims to enhance self-care options for consumers by making effective medications more readily available in pharmacies, supermarkets, and online platforms.

Camect

Pre Seed Round in 2020
Camect Inc., established in 2017 and headquartered in Mountain View, California, specializes in manufacturing smart network video recorders for various camera brands. The company's flagship product, Camect Home, offers continuous recording, remote viewing via home networks, and AI-powered intelligent alert detection. Additionally, Camect Go, a web-based subscription service, provides remote access from anywhere outside the home, delivers alerts through multiple channels, backs up motion videos to cloud storage, and facilitates content sharing with others.

Strella Biotechnology

Seed Round in 2020
Strella Biotechnology, founded in 2018 and headquartered in Philadelphia, Pennsylvania, focuses on enhancing the freshness of produce throughout the supply chain. The company specializes in designing and manufacturing sensors that detect ethylene gas, a key indicator of ripeness in fruits. By measuring ethylene production, Strella's technology helps optimize freshness and minimize spoilage. The company leverages its proprietary sensing technology to provide valuable data for improving supply chain management in the food industry.

Left Hand Robotics

Series A in 2019
Left Hand Robotics, Inc. is a company that specializes in developing commercial-class smart robots designed for outdoor labor-intensive tasks. The firm offers the RT-1000 ROBOT, an autonomous workbot capable of performing various outdoor jobs such as mowing grass and clearing snow without human intervention. This robot can be equipped with attachments like the MOWER DECK for cutting large grassy areas and the SNOW BROOM for snow clearance. Additionally, the DEICER BOX can be added to manage slippery surfaces like sidewalks and bike paths. Incorporated in 2016 and headquartered in Longmont, Colorado, Left Hand Robotics is notable for its self-driving snow-clearing technology, which uses GPS for navigation and can be monitored remotely through an online management dashboard, allowing for efficient and effective outdoor maintenance solutions.

Advanced Farm Technologies

Series A in 2019
Advanced Farm Technologies Inc. is a robotics company specializing in automated strawberry harvesting services in the Oxnard, Santa Maria, and Salinas-Watsonville regions of California. Founded in 2017 and headquartered in Davis, the company focuses on developing advanced robotic solutions that efficiently and delicately handle strawberries, minimizing bruising and damage to the fruit. This innovative approach aims to enhance the efficiency of agricultural operations and support the growing demand for high-quality produce.

Rinicare

Venture Round in 2018
Rinicare Ltd. is a healthcare technology company based in Macclesfield, United Kingdom, specializing in the design and manufacture of innovative monitoring devices. The company offers a range of products, including the PRIME device, which utilizes wireless sensors for vital sign monitoring and data analysis, allowing clinicians to remotely visualize, transmit, and store patient data. Additionally, Rinicare has developed PRIME IoT, which facilitates the transmission of vital sign data to compatible devices through healthcare application software. The company also focuses on patient safety with its SAFE system, a falls detection and prevention solution that employs thermal imaging sensors and intelligent algorithms to monitor patients' positions in bed, alerting clinicians to potential fall risks. Through these technologies, Rinicare aims to enhance patient care by providing real-time insights that support informed decision-making in clinical settings. Established in 2002, Rinicare continues to innovate within the healthcare sector.

Renephra

Seed Round in 2018
Renephra Ltd., established in 2009 and headquartered in Manchester, UK, is a medical device company specializing in controlled fluid removal from the skin. Its core product employs Transdermal Fluid Removal (TFR) technology, combining micro-needles with negative pressure therapy to enable minimally invasive extraction of excess interstitial fluid. Renephra targets fluid overload and chronic oedema/lymphoedema in vascular, oncology, and other disease areas, addressing significant unmet clinical needs in an estimated £1 billion global market.

Acea Health

Seed Round in 2018
Acea Health is a digital healthcare company developing an application called Flynotes - a new digital consent platform. Flynotes analyses a number of factors, including the patient’s background, to deliver personalised risks and benefits. Flynotes aims to be the go-to solution for consent in healthcare. .

metaLinear

Seed Round in 2017
metaLinear Ltd. is a biotechnology company based in Alderley Edge, United Kingdom, that specializes in engineering microbial proteomes to discover novel drug targets for difficult-to-treat bacterial infections. Incorporated in 2016, metaLinear employs a proprietary proteome engineering platform that utilizes extensive libraries of randomized proteins to screen for new antibiotic targets. This innovative approach allows the company to identify, characterize, and validate targets efficiently, significantly reducing risks associated with traditional drug discovery processes. By streamlining the identification of key enzymes and proteins, metaLinear aims to facilitate the development of new microbial drugs, ultimately addressing critical challenges in the fight against antibiotic-resistant infections.

MicroBioSensor

Venture Round in 2017
MicroBioSensor is a diagnostics company that specializes in developing disposable point-of-care medical devices for the early detection of bacterial infections. Its products are designed to be user-friendly and accessible for untrained personnel in various healthcare settings, including care homes, pharmacies, and general practice offices. The company focuses on providing solutions for early infection detection in patients undergoing peritoneal dialysis and for identifying urinary tract infections, including antibiotic selection. By embedding its tests in existing medical devices such as dialysis equipment and wound dressings, MicroBioSensor aims to enhance patient care through timely interventions at a cost-effective price.

Elucid mHealth

Series A in 2017
Elucid mHealth Limited is a medication technology company based in Manchester, United Kingdom, established in 2013. The company specializes in developing adherence monitoring tools and a virtual health platform designed to enhance the efficiency of clinical trials. Its flagship product, Pill Connect, enables trial organizers to access real-time data on medication adherence, helping to prevent missed doses and ensuring protocol compliance. The system facilitates engagement measurements and automated dose reconciliation, thereby improving overall clinical trial outcomes and patient adherence. Elucid mHealth is committed to leveraging innovative technology to support healthcare providers and enhance patient care.

Proveca

Venture Round in 2017
Proveca Ltd. is a pharmaceutical company based in Daresbury, United Kingdom, founded in 2010. The company specializes in identifying, researching, and licensing off-patent medicines aimed at addressing unmet medical needs, particularly within the pediatric market. Proveca's product portfolio includes formulations for conditions such as sialorrhoea, epilepsy, heart failure, and acute pain management. By developing the necessary clinical data and formulations, Proveca aims to secure Paediatric Use Marketing Authorisation (PUMA), which provides a decade of market protection, along with the potential to obtain Orphan Drug status for additional market exclusivity. The company seeks to commercialize its licensed medicines or sell licenses to larger pharmaceutical firms, ensuring that essential treatments are accessible to children in appropriate formats.

AMR Centre

Venture Round in 2017
AMR Centre Limited, established in 2016 and headquartered in Macclesfield, UK, specializes in the development of novel antibiotics to combat antimicrobial resistance. The company offers its expertise and facilities to global pharmaceutical entities on a collaborative basis, with an agreement to share commercially in any successful new products resulting from these partnerships.

Apex Molecular

Venture Round in 2016
Apex Molecular Ltd is a specialist chemistry services provider based in Alderley Edge, United Kingdom, serving the pharmaceutical, biotechnology, and applied chemistry sectors. Established in 2008 and formerly known as YProTech Ltd, the company offers a range of laboratory-scale chemistry development services, including high potency synthesis, custom synthesis, and development and scale-up processes. Apex Molecular is dedicated to delivering timely, dependable, and cost-effective solutions tailored to the needs of its clients, which include drug discovery, biotechnology, and agritech companies. The company employs a flexible approach to project design, ensuring that clients can manage their project portfolios with minimal risk and time delays, thereby facilitating efficient and effective outcomes in their research and development efforts.

SwabTech

Seed Round in 2016
SwabTech Ltd is a UK-based medical device company that originated from the National Health Service (NHS) to create an innovative solution for blood recovery in surgical settings. The company specializes in the development of an automated Surgical Swab Washer designed to improve the effectiveness of intraoperative cell salvage. This device automates the extraction of blood from surgical swabs used during procedures characterized by significant blood loss. By facilitating the recovery and reuse of this blood, SwabTech's technology supports autologous transfusions at the point of need, thereby enhancing patient outcomes and offering a cost-effective approach to managing surgical blood loss. The patented design of the Surgical Swab Washer aims to streamline a process traditionally performed by hand, ensuring that surgeons have timely access to critical resources during emergencies.

Blueberry Therapeutics

Venture Round in 2016
Blueberry Therapeutics Ltd. is a pharmaceutical company focused on developing innovative therapies for diseases where infection and inflammation play significant roles, particularly in dermatological disorders. Founded in 2011 and based in Alderley Edge, United Kingdom, the company utilizes a proprietary nano polymer drug delivery platform to enhance the efficacy of its treatments. Blueberry Therapeutics specializes in formulating candidate drugs that address conditions such as atopic dermatitis, acne, and wound healing, while also targeting inflammatory bowel disease. By employing advanced preclinical research technologies, the company aims to create safe and effective medicines that address critical healthcare needs and improve patient outcomes. Through its commitment to well-validated drug targets and a focus on minimizing toxicity, Blueberry Therapeutics seeks to reduce the risk of drug failures during clinical development.

Biorelate

Seed Round in 2016
Biorelate Ltd., founded by Daniel Jamison in 2014, is a biomedical research company based in Oldham, United Kingdom. The company specializes in providing services for the development of biomarkers aimed at diagnosing prostate cancer, validating targets, and advancing new drug development. Biorelate's platform curates biomedical knowledge to support innovations in biotechnological research, offering functions such as auto-curating valuable data from various text sources and automatically ingesting information to identify causal interactions between genes, chemicals, drugs, cells, and phenotypes. This enables scientists to conduct more efficient research in drug discovery, cancer diagnosis, and target validation.

Kanichi Research Services

Venture Round in 2016
Kanichi Research Services specializes in developing innovative non-invasive diagnostic systems that analyze exhaled breath to facilitate the rapid detection and diagnosis of various diseases. The company’s flagship product is a cost-effective, disposable point-of-care test designed to identify Helicobacter Pylori, a bacterial infection associated with stomach ulcers and cancer. In addition to its diagnostic offerings, Kanichi Research Services manufactures bespoke electrochemical components, including custom-made electrodes, which enhance advanced sensor systems. These components enable the detection of a wide array of chemical and biological molecules across air, breath, and liquid media.

Arlabion

Seed Round in 2016
Arlabion Ltd is an agri-tech company based in Huddersfield, United Kingdom, that specializes in developing innovative agrochemicals aimed at sustainable crop management. Founded in 2014, Arlabion focuses on creating seed treatments that protect crops from fungal infections and enhance the plant's immune system. Their technology not only promotes improved seed germination and root system development but also minimizes the risk of fungal diseases threatening essential food crops. By leveraging established organic chemistry techniques traditionally used in human and animal healthcare, Arlabion addresses the growing demand for safer and less harmful solutions in agriculture. The company's commitment to developing effective, environmentally friendly crop protection products positions it within a dynamic and expanding market.

Monica Healthcare

Seed Round in 2015
Monica Healthcare, based in Nottingham, United Kingdom, is a manufacturer of advanced fetal monitoring devices aimed at improving obstetric care. Founded in 2005, the company specializes in innovative wearable technologies that utilize wireless systems to monitor maternal heart rate, fetal heart rate, and uterine activity. One of its key products is The Novii, a single-use wireless patch designed for both hospital and home use. Monica Healthcare's devices are intended to enhance the birth experience for midwives, labor and delivery nurses, and expectant mothers, while also facilitating access to obstetric services. In addition to its product offerings, the company provides training, repairs, and support services to its customers. Since 2017, Monica Healthcare has been operating as a subsidiary of GE Healthcare.

Michelson Diagnostics

Series A in 2014
Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography (OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 µm resolution,in real time, to depths of 1 mm or more.

4Energy

Corporate Round in 2013
4Energy, based in Nottingham, specializes in innovative cooling solutions that achieve significant energy savings, reportedly up to 50% compared to traditional cooling products. The company has developed an Internet of Things (IoT) software platform that integrates data from both new and existing meters from various vendors. This platform facilitates the connection of buildings and systems, providing a centralized overview of utility usage in industrial and commercial environments, including data centers, telecom communication rooms, and base stations. By leveraging this technology, 4Energy enhances the efficiency of cooling systems and supports demand-side response initiatives, enabling users to optimize energy consumption and achieve network-free cooling solutions.

Activ8 Intelligence

Venture Round in 2013
Activ8 Intelligence Limited is a UK-based company specializing in human resources reporting and analytics solutions that enhance the connection between HR practices and business outcomes. Founded in 2005, the company provides a range of services, including HR reporting tools, predictive workforce planning, and consulting aimed at optimizing recruitment and talent management strategies. Its offerings include performance indicators, dashboards, and various analytic tools designed to present data in accessible formats for decision-makers. Activ8 also features predictive solutions tailored for hiring, employee retention, and analysis, empowering organizations to make informed decisions based on workforce data. The company's focus is on transforming raw data into actionable insights, facilitating better understanding of workforce trends and metrics.

Haemostatix

Venture Round in 2012
Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in developing a peptide-based platform technology aimed at creating innovative products for controlling surgical bleeding and promoting tissue repair. Its primary product, PeproStat, is a coagulant that can be directly applied to surgical wounds to effectively manage bleeding. Haemostatix’s technology utilizes a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation. This platform supports a diverse pipeline of first-in-class hemostatic products designed to address various bleeding scenarios, including those encountered in surgery, trauma, and among leukaemic patients. Haemostatix operates as a subsidiary of Ergomed plc.

Biofortuna

Venture Round in 2012
Biofortuna Limited is a molecular diagnostics company based in Wirral, United Kingdom, founded in 2008. The company specializes in the development and manufacture of freeze-dried HLA molecular diagnostic kits, including its SSPGo solution for genotyping and Verdict software for analyzing test results. Biofortuna's products cater to various applications, such as companion diagnostics, clinical testing, bio-defense, and food and veterinary diagnostics. Additionally, the company provides contract development and manufacturing services for cryo-preservatives and IVD kits, as well as custom assay development for clients in healthcare. Biofortuna's innovative technology allows for the transformation of PCR tests into freeze-dried formats, enhancing the stability and usability of molecular reagents. The company's offerings serve a global customer base through a network of distributors.

Echo

Venture Round in 2012
Echo Ltd. is a company that specializes in providing a comprehensive range of IT and logistical support services through an outsourced partnership model. Established in 2010 and headquartered in Oklahoma City, Oklahoma, the firm focuses on delivering tailored solutions that enhance existing service portfolios, thereby improving cost efficiency while upholding high-quality service standards. Additionally, Echo Investment Capital, the corporate venture capital arm of Echo Energy, seeks investment opportunities in various sectors, including life sciences, technology, media, education, and real estate.

Comply Serve

Venture Round in 2012
Comply Serve is a software company based in Solihull, United Kingdom, specializing in compliance and validation solutions tailored for highly regulated industries. Founded in 2005, the company offers ComplyPro, a cloud-based platform designed to ensure compliance of large-scale infrastructure projects throughout their design, build, and delivery phases. This platform facilitates collaborative work between clients and supply chains, enabling better-informed decisions that reduce project failures and enhance outcomes. Comply Serve serves industries such as rail, infrastructure, aviation, energy, and safety worldwide. The company evolved from Telelogic AB and became a subsidiary of Bentley Systems in 2016.

Michelson Diagnostics

Venture Round in 2012
Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography (OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 µm resolution,in real time, to depths of 1 mm or more.

BioFilm

Venture Round in 2012
BioFilm Limited is a manufacturer and developer of thin dissolvable films, catering to various sectors including nutritional supplements, cosmetics, dental care, and medical devices across Europe. Founded in 2003 and based in Glasgow, United Kingdom, the company specializes in a diverse range of film products, such as oral care films for teeth whitening and mouth ulcers, food supplement films featuring substances like potassium iodide and melatonin, and wound care films. BioFilm also produces specialty films for breath freshening, dry mouth, and anti-snoring applications. Additionally, the company operates as a private label developer, creating custom film products for pharmaceutical, consumer goods, and retail industries. BioFilm Limited was previously known as Biofilm Manufacturing Limited and rebranded in July 2005.

Stage Coach

Acquisition in 2012
Stagecoach is a network of performing arts schools that teaches children and young people to sing, dance and act in a fun, educational, and stimulating environment

Biofortuna

Venture Round in 2012
Biofortuna Limited is a molecular diagnostics company based in Wirral, United Kingdom, founded in 2008. The company specializes in the development and manufacture of freeze-dried HLA molecular diagnostic kits, including its SSPGo solution for genotyping and Verdict software for analyzing test results. Biofortuna's products cater to various applications, such as companion diagnostics, clinical testing, bio-defense, and food and veterinary diagnostics. Additionally, the company provides contract development and manufacturing services for cryo-preservatives and IVD kits, as well as custom assay development for clients in healthcare. Biofortuna's innovative technology allows for the transformation of PCR tests into freeze-dried formats, enhancing the stability and usability of molecular reagents. The company's offerings serve a global customer base through a network of distributors.

Oracle Care & Education

Venture Round in 2011
Oracle Care & Education specializes in providing comprehensive educational, therapeutic, and residential care services for young people aged ten to eighteen with complex needs. Operating primarily in Staffordshire and Bedfordshire, the organization focuses on creating a supportive and safe environment that fosters positive relationships and enhances self-esteem. By integrating care with education, Oracle Care aims to empower children, equipping them with the skills and confidence necessary to build a brighter future.

Hangar Seven

Venture Round in 2011
Hangar Seven Limited is a creative production company that offers comprehensive marketing services tailored for retailers and consumer brands globally. Established in 2007 and headquartered in Macclesfield, United Kingdom, with additional facilities in London, South Manchester, Leeds, and Portugal, the company specializes in content creation, management, and distribution. Hangar Seven provides a range of services including asset management, digital marketing production, photography, packaging, and retail marketing. The firm effectively engages consumers through various channels such as point of sale, online platforms, social media, and traditional advertising, including press and broadcast. With a commitment to delivering high-quality marketing solutions in a cost-effective manner, Hangar Seven serves clients and agencies from its expansive 50,000 square foot facilities, distributing marketing assets to over 87 countries worldwide. As of 2017, Hangar Seven operates as a subsidiary of The Hut.com Ltd.

5Degrees

Seed Round in 2011
5Degrees is a company that specializes in developing mobile and web-based customer relationship management (CRM) tools tailored for startups and small businesses. Founded in June 2011 and based in Chicago, Illinois, 5Degrees offers a suite of products that includes a CRM application for iPhone, a business card scanning app, and a web-based CRM platform. These tools allow users to efficiently manage their contacts by importing data from various sources, organizing connections into manageable groups, and utilizing features such as task scheduling, templated emails, and reminders. Additionally, the platform integrates with services like LinkedIn and Box.com, supports multi-device synchronization, and provides offline access, thereby enhancing the user experience in maintaining and nurturing professional relationships.

Haemostatix

Series C in 2011
Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in developing a peptide-based platform technology aimed at creating innovative products for controlling surgical bleeding and promoting tissue repair. Its primary product, PeproStat, is a coagulant that can be directly applied to surgical wounds to effectively manage bleeding. Haemostatix’s technology utilizes a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation. This platform supports a diverse pipeline of first-in-class hemostatic products designed to address various bleeding scenarios, including those encountered in surgery, trauma, and among leukaemic patients. Haemostatix operates as a subsidiary of Ergomed plc.

KickSport

Venture Round in 2011
KickSport is a specialized retailer focused on providing high-quality martial arts equipment and uniforms for disciplines such as Judo, Karate, and Taekwondo. The company operates an online shopping platform that caters to a diverse range of sports, including boxing and wrestling, ensuring customers have access to a wide array of assured quality products in one place. KickSport emphasizes exceptional customer service and is driven by values such as energy, dedication, leadership, evolution, aspiration, community, fashion, and quality. Through its commitment to these principles, KickSport aims to enhance the experience of athletes and practitioners in various physical sports.

Intelligent Orthopaedics

Venture Round in 2011
Intelligent Orthopaedics, established in 2002 and based in Newcastle-under-Lyme, UK, specializes in designing, developing, and manufacturing orthopedic trauma devices for treating tibia fractures. Their flagship product is STORM (The Staffordshire Orthopaedic Reduction Machine), a reusable surgical device facilitating fracture reduction across the tibia. Additionally, they offer IOS, a single-use fixator for stabilizing tibial shaft fractures. As of September 2016, the company has ceased operations due to liquidation.

Haemostatix

Venture Round in 2010
Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in developing a peptide-based platform technology aimed at creating innovative products for controlling surgical bleeding and promoting tissue repair. Its primary product, PeproStat, is a coagulant that can be directly applied to surgical wounds to effectively manage bleeding. Haemostatix’s technology utilizes a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation. This platform supports a diverse pipeline of first-in-class hemostatic products designed to address various bleeding scenarios, including those encountered in surgery, trauma, and among leukaemic patients. Haemostatix operates as a subsidiary of Ergomed plc.

Oxford Cryosystems

Acquisition in 2010
Oxford Cryosystems Ltd is a leading manufacturer of specialized scientific cooling instruments and software, primarily focusing on cryogenic applications. Founded in the 1960s and evolved from a laboratory at Oxford University, the company has developed a range of products under the Cryostream brand, including low-temperature systems for X-ray crystallography and open-flow coolers for various applications. Its offerings extend to Gifford McMahon cryocoolers, Coolstar coldheads, and Crystallographica software for crystallographic research and analysis. Serving a diverse clientele that includes universities, high-tech manufacturers, pharmaceutical companies, and research institutes, Oxford Cryosystems exports over 80% of its production globally, while maintaining strong ties with British suppliers for at least 90% of its components. The company is headquartered in Oxford, United Kingdom, and has approximately 20 employees.

nanoTherics

Venture Round in 2010
nanoTherics Limited specializes in the development and provision of scientific devices and products tailored for the biotechnology, life science, and pharmaceutical sectors. Founded in 2007 and headquartered in Stoke-on-Trent, United Kingdom, the company offers a range of innovative tools including magneTherm, which facilitates magnetic fluid and nanoparticle hyperthermia testing, and live cell systems for in vitro imaging. Additionally, nanoTherics provides magnefect systems, which encompass magnetic nanoparticles and lipid-based transfection reagents designed for efficient biomaterial delivery into cells. The company’s technologies have shown significant advancements in gene transfection, exhibiting enhanced performance and maintaining cell viability, thereby establishing a competitive edge in the market. nanoTherics aims to set a new standard in gene transfection technology, supporting the ongoing research and development of gene therapy applications. Its products are available for purchase online, catering to various in vivo and clinical applications, including drug screening and cancer therapy.

Yospace Technologies

Venture Round in 2010
Yospace Technologies is a mobile applications innovator and platform provider based in Staines-upon-Thames, United Kingdom. Founded in 1999, the company specializes in delivering mobile video services to digital publishers, mobile application developers, and mobile operators. Yospace offers advanced technology for intelligent streaming, allowing for effective ad insertion and replacement, which helps content owners monetize their offerings. The company's yospaceCDS platform supports both live and on-demand video services with in-stream ad insertion. Additionally, Yospace provides a range of broadcast head-end solutions that facilitate stream conditioning and ad avail detection necessary for dynamic ad insertion in live streaming. By serving as middleware between existing advertising infrastructure, Yospace enables clients to track audience demographics and tailor advertisements, thereby increasing CPM rates while maintaining seamless integration with existing workflows.

Silver Lining Solutions

Venture Round in 2010
Silver Lining Solutions Limited specializes in developing employee performance optimization software tailored for international call centers. Founded in 1999 and headquartered in Solihull, United Kingdom, with additional offices in Asia Pacific and the United States, the company focuses on enhancing employee engagement and performance by identifying and leveraging individual skills and knowledge. Its software solutions enable organizations to efficiently route customer inquiries to the most qualified personnel, while also providing tools for performance assessment, training scheduling, and development planning. By facilitating the validation of employees' skills and behaviors through feedback mechanisms, Silver Lining Solutions helps businesses achieve significant improvements in customer experience, sales performance, and operational efficiencies. The company has established strategic partnerships with several industry leaders, enhancing its ability to serve a diverse client base across various sectors.

Renewable Technical Services Limited

Venture Round in 2010
Renewable Technical Services Limited is a provider of installation, repair and maintenance services to the wind energy sector. The company supports major OEMs under preferred supplier / framework agreements, as well as working for the major power companies and wind-farm operators under long-term arrangements. With over 20 years of experience in installation and maintenance of met masts and wind turbines, the RTS team is available 24 hours a day, 7 days a week to support the wind energy industry. Having provided services to over 268 wind farms in the UK, it has worked on over 5,000 wind turbines. Our reach extends further still, with RTS engineers having worked on contracts in New Zealand, the Dominican Republic, Libya, South Africa and throughout Europe.

Biofortuna

Venture Round in 2010
Biofortuna Limited is a molecular diagnostics company based in Wirral, United Kingdom, founded in 2008. The company specializes in the development and manufacture of freeze-dried HLA molecular diagnostic kits, including its SSPGo solution for genotyping and Verdict software for analyzing test results. Biofortuna's products cater to various applications, such as companion diagnostics, clinical testing, bio-defense, and food and veterinary diagnostics. Additionally, the company provides contract development and manufacturing services for cryo-preservatives and IVD kits, as well as custom assay development for clients in healthcare. Biofortuna's innovative technology allows for the transformation of PCR tests into freeze-dried formats, enhancing the stability and usability of molecular reagents. The company's offerings serve a global customer base through a network of distributors.

Oxford Biotherapeutics

Venture Round in 2010
Oxford Biotherapeutics Ltd is a biotechnology company focused on developing innovative antibody therapies for cancer treatment. The company specializes in antibody-drug conjugates, aiming to create targeted therapies that improve treatment outcomes for patients. Its proprietary OGAP (Oxford Genome Anatomy Project) platform, one of the largest human protein databases globally, facilitates the identification of validated and novel antigen targets across various cancer types. Key products include OBT076, an antibody-drug conjugate aimed at treating high-risk HER2 negative breast cancer and other solid tumors. Additionally, Oxford Biotherapeutics is developing antibody-based treatments for conditions such as acute myeloid leukemia and plans to integrate companion diagnostics into its programs to enhance disease management. Established in 2003, the company is based in Oxon, United Kingdom, with an operational site in San Jose, California, and maintains strategic collaborations with leading antibody-focused firms to broaden its therapeutic pipeline.

Zinwave

Funding Round in 2010
Zinwave UK is a global provider specializing in wideband active distributed antenna systems designed to enhance in-building wireless coverage. The company manufactures patented ultra-wideband radio frequency fiber solutions tailored for various sectors, including commercial real estate, healthcare, hospitality, enterprise, public venues, wholesale data centers, and education. By offering advanced in-building wireless products and services, Zinwave optimizes connectivity for mobile network operators, integrators, and end users through its innovative wideband technology.

Intellitect Water Holdings

Venture Round in 2010
Intellitect specializes in developing advanced water quality monitoring systems that enhance the ability of water companies to ensure the safety and quality of their products as they move through distribution networks. Their Insight system is designed to monitor drinking water, wastewater, and natural water resources by utilizing multiparameter instruments that gather and analyze various water quality metrics. This system provides real-time alerts and detailed information about potential quality issues, allowing users to quickly identify problems and respond effectively. By transmitting data to individual sensors and devices, Intellitect enables clients to access comprehensive statistics that support informed decision-making and help maintain high standards of water quality throughout the distribution process.

Intamac Systems

Venture Round in 2009
Intamac Systems Ltd. is a technology company that specializes in providing a cloud-based platform for the Internet of Things (IoT), enabling connectivity for various home and business applications. Founded in 2000 and headquartered in Northampton, United Kingdom, with additional offices in Cambridge and Trivandrum, the company offers monitoring and control services that connect diverse products, appliances, and devices through its internet platform. This open platform facilitates two-way communication, allowing users to monitor and control their systems via mobile phones or the internet, and provides essential alerts for issues such as power failures, floods, fires, burglaries, and camera activations. Intamac also supports original equipment manufacturers (OEMs) and product vendors by evolving their business models and enhancing customer engagement through tailored IoT solutions, including a full access license program that allows companies to manage and develop their custom software with reduced risk.

Probe Scientific

Series A in 2009
Probe Scientific Ltd. is a medical device company based in Coventry, United Kingdom, focused on developing innovative diagnostic products to address clinical challenges and enhance healthcare outcomes. Founded in 1998, the company has established a diverse product pipeline centered around proprietary technologies. Its notable offerings include MicroEye, which allows for continuous online blood sampling without the need for full blood withdrawal; ContinuMon, an external monitoring system for lactate and glucose levels; and NanoEye, a compact monitoring device intended for neonatal and pediatric intensive care. Probe Scientific's automated blood sampling technology supports various applications, including critical care, therapeutic drug monitoring, clinical studies, and personalized medicine. The company has experienced steady growth since its inception and has recently expanded its leadership team to bolster its commercial focus.

Accutronics

Venture Round in 2009
Accutronics Ltd is a design and manufacturing company based in Newcastle under Lyme, United Kingdom, specializing in rechargeable batteries and chargers for portable and handheld electronic devices. Established in 2009, the company focuses on the development of 'smart batteries' that incorporate advanced technologies such as electronic fuel gauging and active safety systems. Accutronics serves a diverse range of markets, including military, defense, security, medical, industrial electronics, and portable electronic equipment, providing custom-designed battery packs and chargers tailored for professional applications. The company's expertise allows original equipment manufacturers (OEMs) to enhance the performance of their devices, making them smaller, lighter, and safer. Accutronics also distributes a variety of standard smart batteries and accessories, further expanding its product offerings in the battery technology sector.

Systems Integration (Trading) Limited

Private Equity Round in 2009
Systems Integration (Trading) Limited is a company that specializes in providing software and hardware solutions tailored for the food processing industry. Incorporated in 1994 and based in Lichfield, United Kingdom, it offers a range of systems designed to enhance operational efficiency. Key products include Sistem 7 SHOP FLOOR DATA CAPTURE, which automates the collection and transfer of data; Sistem 7 SALES ORDER PROCESSING, featuring an intuitive Explorer interface; and Sistem 7 BONING HALL, which facilitates the management of stock at the boning hall. Additionally, the company provides tools such as Sistem 7 OUTER CASE MARKER for weighing and labeling products, Sistem 7 DESPATCH & TRACKER for monitoring order statuses, and Sistem 7 STOCK & TRACKER for inventory management. Systems Integration (Trading) Limited also offers support services, including help desk assistance, remote diagnostics, software upgrades, and operational consultancy.

Systems Integration

Venture Round in 2009
Systems Integration is a leading provider of hardware and software solutions tailored specifically for the meat processing industry. Leveraging extensive industry knowledge, the company develops enterprise resource planning (ERP) and manufacturing execution system (MES) software that addresses key challenges such as regulatory compliance, margin improvement, and quality control. Their product offerings include food ERP, MES, and specialized applications for shop-floor data capture, planning, quality assurance, and traceability. By integrating state-of-the-art technology with bespoke software, Systems Integration enables organizations to streamline their supply chains, enhance operational efficiencies, reduce waste, and ultimately improve profitability.

Monica Healthcare

Venture Round in 2009
Monica Healthcare, based in Nottingham, United Kingdom, is a manufacturer of advanced fetal monitoring devices aimed at improving obstetric care. Founded in 2005, the company specializes in innovative wearable technologies that utilize wireless systems to monitor maternal heart rate, fetal heart rate, and uterine activity. One of its key products is The Novii, a single-use wireless patch designed for both hospital and home use. Monica Healthcare's devices are intended to enhance the birth experience for midwives, labor and delivery nurses, and expectant mothers, while also facilitating access to obstetric services. In addition to its product offerings, the company provides training, repairs, and support services to its customers. Since 2017, Monica Healthcare has been operating as a subsidiary of GE Healthcare.

Warwick Effect Polymers

Venture Round in 2009
Warwick Effect Polymers Limited manufactures and markets complex polymers using living controlled radical polymerization.

Comply Serve

Venture Round in 2009
Comply Serve is a software company based in Solihull, United Kingdom, specializing in compliance and validation solutions tailored for highly regulated industries. Founded in 2005, the company offers ComplyPro, a cloud-based platform designed to ensure compliance of large-scale infrastructure projects throughout their design, build, and delivery phases. This platform facilitates collaborative work between clients and supply chains, enabling better-informed decisions that reduce project failures and enhance outcomes. Comply Serve serves industries such as rail, infrastructure, aviation, energy, and safety worldwide. The company evolved from Telelogic AB and became a subsidiary of Bentley Systems in 2016.

Comply

Venture Round in 2009
Comply provides specialized, off-the-shelf scientific and process data management software products, and offers Professional Consulting Services to support and enhance Life Science companies in successfully meeting unique industry demands.

Oxford Biotherapeutics

Venture Round in 2009
Oxford Biotherapeutics Ltd is a biotechnology company focused on developing innovative antibody therapies for cancer treatment. The company specializes in antibody-drug conjugates, aiming to create targeted therapies that improve treatment outcomes for patients. Its proprietary OGAP (Oxford Genome Anatomy Project) platform, one of the largest human protein databases globally, facilitates the identification of validated and novel antigen targets across various cancer types. Key products include OBT076, an antibody-drug conjugate aimed at treating high-risk HER2 negative breast cancer and other solid tumors. Additionally, Oxford Biotherapeutics is developing antibody-based treatments for conditions such as acute myeloid leukemia and plans to integrate companion diagnostics into its programs to enhance disease management. Established in 2003, the company is based in Oxon, United Kingdom, with an operational site in San Jose, California, and maintains strategic collaborations with leading antibody-focused firms to broaden its therapeutic pipeline.

Key Technologies

Seed Round in 2008
Key Technologies Ltd. is a specialist engineering company based in Cradley Heath, United Kingdom, established in 2003. The company focuses on providing engineering solutions primarily within the Defense and Homeland Security sectors. It manufactures and supplies a range of products, including specialist ammunition, 12 gauge rounds, explosive ordnance disposal (EOD) equipment, and public order solutions, distributing these products globally. In addition to its manufacturing capabilities, Key Technologies engages in design, electronic manufacturing, and through-life system engineering services, offering comprehensive support throughout the lifecycle of its products.

4energy

Venture Round in 2008
4energy Ltd. develops energy cooling systems and platforms for telecommunications and equipment rooms.

4Energy

Venture Round in 2008
4Energy, based in Nottingham, specializes in innovative cooling solutions that achieve significant energy savings, reportedly up to 50% compared to traditional cooling products. The company has developed an Internet of Things (IoT) software platform that integrates data from both new and existing meters from various vendors. This platform facilitates the connection of buildings and systems, providing a centralized overview of utility usage in industrial and commercial environments, including data centers, telecom communication rooms, and base stations. By leveraging this technology, 4Energy enhances the efficiency of cooling systems and supports demand-side response initiatives, enabling users to optimize energy consumption and achieve network-free cooling solutions.

Sight and Sound Technology

Acquisition in 2008
Sight and Sound Technology Limited is a UK-based company that specializes in distributing assistive hardware and software solutions for individuals with visual impairments and learning difficulties. Founded in 1982 and headquartered in Northampton, the company provides a wide range of products including braille displays, electronic video magnifiers, screen readers, talking barcode scanners, and text-to-speech technology. In addition to its product offerings, Sight and Sound Technology also delivers services such as training, solution design, and customer support, ensuring comprehensive assistance for its clients. The company caters to various sectors, including individuals, charities, government bodies, educational institutions, and corporations. With a commitment to enhancing the lives of those with sensory disabilities, Sight and Sound Technology plays a vital role in helping users improve their daily activities and achieve their full potential.

Oxford Biotherapeutics

Venture Round in 2008
Oxford Biotherapeutics Ltd is a biotechnology company focused on developing innovative antibody therapies for cancer treatment. The company specializes in antibody-drug conjugates, aiming to create targeted therapies that improve treatment outcomes for patients. Its proprietary OGAP (Oxford Genome Anatomy Project) platform, one of the largest human protein databases globally, facilitates the identification of validated and novel antigen targets across various cancer types. Key products include OBT076, an antibody-drug conjugate aimed at treating high-risk HER2 negative breast cancer and other solid tumors. Additionally, Oxford Biotherapeutics is developing antibody-based treatments for conditions such as acute myeloid leukemia and plans to integrate companion diagnostics into its programs to enhance disease management. Established in 2003, the company is based in Oxon, United Kingdom, with an operational site in San Jose, California, and maintains strategic collaborations with leading antibody-focused firms to broaden its therapeutic pipeline.

Silver Lining Solutions

Venture Round in 2008
Silver Lining Solutions Limited specializes in developing employee performance optimization software tailored for international call centers. Founded in 1999 and headquartered in Solihull, United Kingdom, with additional offices in Asia Pacific and the United States, the company focuses on enhancing employee engagement and performance by identifying and leveraging individual skills and knowledge. Its software solutions enable organizations to efficiently route customer inquiries to the most qualified personnel, while also providing tools for performance assessment, training scheduling, and development planning. By facilitating the validation of employees' skills and behaviors through feedback mechanisms, Silver Lining Solutions helps businesses achieve significant improvements in customer experience, sales performance, and operational efficiencies. The company has established strategic partnerships with several industry leaders, enhancing its ability to serve a diverse client base across various sectors.

Haemostatix

Venture Round in 2008
Haemostatix Ltd. is a biotechnology company based in Nottingham, United Kingdom, founded in 2003 as a spin-out from the University of Leicester. The company specializes in developing a peptide-based platform technology aimed at creating innovative products for controlling surgical bleeding and promoting tissue repair. Its primary product, PeproStat, is a coagulant that can be directly applied to surgical wounds to effectively manage bleeding. Haemostatix’s technology utilizes a specific peptide sequence that binds to fibrinogen, a crucial protein in clot formation. This platform supports a diverse pipeline of first-in-class hemostatic products designed to address various bleeding scenarios, including those encountered in surgery, trauma, and among leukaemic patients. Haemostatix operates as a subsidiary of Ergomed plc.

BWB Consulting

Private Equity Round in 2008
BWB Consulting is an integrated engineering and environmental consultancy that delivers multi-disciplinary engineering solutions to the property, development and construction industry. BWB Consulting provides over 70 services, in 15 sectors to an international client base. It offers building and built environment services ranging from designing new buildings to adapting, refurbishing, and maintaining existing building stocks; and from initial feasibility study to planning, detailed design, construction, routine maintenance, decommissioning, and demolition services for public and private sector development projects. Its environment services include advisory, investigative, design, and validation services relating to various aspects of the ground and water environment. The company also provides transport and infrastructure services, which include planning and designing multi-modal transport infrastructure. It serves industrial and manufacturing, education, retail, leisure and hospitality, residential, distribution, energy and carbon, retail, urban regeneration, commercial, health, public, culture and heritage, road and rail, finance and investment, and water environment sectors. The company was founded in 1990 and is based in Nottingham, United Kingdom. As of July 12, 2017, BWB Consulting Limited operates as a subsidiary of Construcciones y Auxiliar de Ferrocarriles, S.A.

Activ8 Intelligence

Venture Round in 2008
Activ8 Intelligence Limited is a UK-based company specializing in human resources reporting and analytics solutions that enhance the connection between HR practices and business outcomes. Founded in 2005, the company provides a range of services, including HR reporting tools, predictive workforce planning, and consulting aimed at optimizing recruitment and talent management strategies. Its offerings include performance indicators, dashboards, and various analytic tools designed to present data in accessible formats for decision-makers. Activ8 also features predictive solutions tailored for hiring, employee retention, and analysis, empowering organizations to make informed decisions based on workforce data. The company's focus is on transforming raw data into actionable insights, facilitating better understanding of workforce trends and metrics.

r2c Online

Seed Round in 2008
r2c Online Limited is a company based in Sheffield, United Kingdom, that specializes in providing an online platform for compliance, quoting, authorization, and invoicing within the road transport industry in Europe. Founded in 2003, r2c Online connects vehicle manufacturers, dealers, and repairers with workshops, fleet operators, and leasing companies, facilitating efficient communication and management of commercial vehicle inspection and maintenance records. The platform serves a diverse clientele, including small and medium-sized enterprises as well as larger corporate entities, by enabling users to store and access crucial service, inspection, and compliance records. As of April 2019, r2c Online operates as a subsidiary of FleetCor Technologies, Inc.

SolarTech

Venture Round in 2008
SolarTech Ltd. specializes in the design and installation of renewable energy systems aimed at maximizing green energy usage and reducing greenhouse gas emissions. The company offers a comprehensive range of services, including the design, monitoring, supply, installation, and maintenance of various renewable energy solutions such as solar panels, biomass boilers, wind turbines, and heat pumps. By serving the domestic, commercial, and public sectors, SolarTech Ltd. enables its clients to adopt environmentally friendly practices and contribute to sustainability efforts.

Atlantic Link Limited

Venture Round in 2008
Atlantic Link Limited develops rapid e-learning training products which enable users to design and deliver professional on-line training to thousands of employees which would, in the past, have taken months to create at great cost. It offers Content Point, a remote authoring system that enables the development of e-learning courses; Capture Point, a capture tool for the automatic creation of online software training courses; and Knowledge point, a collaboration server and learning management system that provides course launch and tracking, results storage, student import, and user and author grouping functions. The company also specializes in project management, instructional design, branding and design, technical, and account management areas, as well as provides eLearning support and hosted solutions. It serves corporate clients, as well as government and higher education markets through a network of resellers globally. Atlantic Link Limited was founded in 2002 and is based in Nottingham, United Kingdom with an additional office in Atlanta, Georgia.

CellAura

Venture Round in 2008
CellAura Technologies, Ltd. specializes in providing innovative screening products for the drug discovery industry. Originating as a spin-out from the University of Nottingham, the company leverages expertise in synthetic chemistry and molecular pharmacology to develop high-quality fluorescent ligands targeting various receptors, including adenosine, beta-adrenergic, dopamine, histamine, and muscarinic receptors. In addition to its product offerings, CellAura provides a contract fluorescent ligand development and validation service, allowing for the synthesis of custom products accompanied by comprehensive pharmacological characterization. Based in Nottingham, United Kingdom, CellAura aims to enhance molecular pharmacology and imaging capabilities at the single-cell level.

Eden Luxury Group

Venture Round in 2008
Eden Luxury is a Chester-based travel brand that provides high end holidays through its Seasons in Style and Eden Collection.

L3 Technology

Venture Round in 2008
L3 Technology develops a point of care testing system for reading blood analytes from various samples. It offers a lipid profile testing system for measuring a multi-fraction lipid profile from a finger stick sample of blood, serum, or plasma. The company was incorporated in 2001 and is based in Coventry, United Kingdom. As of December 16, 2016, L3 Technology was acquired by Jupiter Diagnostics.

Abzena

Venture Round in 2008
Abzena plc is a biopharmaceutical services company that specializes in the development and manufacturing of biologics and antibody-drug conjugates (ADCs). Operating internationally, it provides a comprehensive range of technologies and solutions that support the discovery, development, and production of biopharmaceutical products. Abzena's offerings include advanced antibody engineering, immunogenicity assessment, and various bioassay and bioanalytic services. The company assists clients from initial concept through to clinical development, focusing on enhancing the efficacy and safety of biotherapeutics. Its services also encompass peptide synthesis, process development, and the characterization of drug conjugates. By partnering with biopharmaceutical companies and academic institutions, Abzena aims to drive innovation and improve therapeutic outcomes for patients. Founded in 2014 and headquartered in Cambridge, United Kingdom, Abzena has positioned itself as a key player in the biologics research sector.

Synchro Software

Venture Round in 2007
Synchro Software Ltd. is a developer of digital construction software, specializing in 4D building information modeling and virtual design and construction solutions. Founded in 2001 and headquartered in Birmingham, United Kingdom, with additional offices in the United States, the company offers a range of tools designed to enhance project management, including a 4D scheduling platform, a multi-user project collaboration solution, and a project file viewer. Synchro's software enables users to visualize construction sites in 3D and 4D, facilitating real-time updates and communication among project participants. Its applications are utilized across various sectors, including commercial, civil, and residential construction projects, aiming to enhance safety, reliability, and overall project quality. Synchro Software operates as a subsidiary of Bentley Systems, further expanding its reach in the construction technology market.

Monica Healthcare

Venture Round in 2007
Monica Healthcare, based in Nottingham, United Kingdom, is a manufacturer of advanced fetal monitoring devices aimed at improving obstetric care. Founded in 2005, the company specializes in innovative wearable technologies that utilize wireless systems to monitor maternal heart rate, fetal heart rate, and uterine activity. One of its key products is The Novii, a single-use wireless patch designed for both hospital and home use. Monica Healthcare's devices are intended to enhance the birth experience for midwives, labor and delivery nurses, and expectant mothers, while also facilitating access to obstetric services. In addition to its product offerings, the company provides training, repairs, and support services to its customers. Since 2017, Monica Healthcare has been operating as a subsidiary of GE Healthcare.

Blackstar Amplification

Private Equity Round in 2007
Blackstar Amplification Limited is a UK-based company located in Northampton, specializing in the design and manufacture of innovative guitar amplifiers and effects pedals. Founded by four directors with over 50 years of combined experience in guitar amplification design and production, the company aims to provide guitarists with the ultimate tools for self-expression. Blackstar's product range includes valve overdrive pedals, hand-wired amplifiers, and amplifiers tailored for studio and practice use. The company is recognized for its commitment to quality and creativity, catering to the diverse needs of musicians.

R5 Pharmaceuticals

Seed Round in 2007
R5 Pharmaceuticals Ltd. engages in the contract development and manufacture of clinical trials materials.

Critical Pharmaceuticals

Series B in 2007
Critical Pharmaceuticals Limited is a biotechnology company based in Nottingham, United Kingdom, founded in 2002 by Professor Steve Howdle. The company specializes in developing innovative drug delivery technologies, including CriticalSorb for non-invasive nasal delivery and CriticalMix for sustained release injectable products. Its portfolio features several therapeutic products aimed at addressing significant medical needs, such as CP024, a nasal growth hormone for growth hormone deficiency, and CP046, a nasal formulation of teriparatide for osteoporosis treatment. Other products include an injectable human growth hormone and a sustained release formulation of Bevacizumab for age-related macular degeneration. Critical Pharmaceuticals employs unique methods, including the use of supercritical carbon dioxide to enhance drug encapsulation in regulatory-approved polymers. As of July 31, 2017, the company was placed under liquidation.

Oxford Biotherapeutics

Venture Round in 2007
Oxford Biotherapeutics Ltd is a biotechnology company focused on developing innovative antibody therapies for cancer treatment. The company specializes in antibody-drug conjugates, aiming to create targeted therapies that improve treatment outcomes for patients. Its proprietary OGAP (Oxford Genome Anatomy Project) platform, one of the largest human protein databases globally, facilitates the identification of validated and novel antigen targets across various cancer types. Key products include OBT076, an antibody-drug conjugate aimed at treating high-risk HER2 negative breast cancer and other solid tumors. Additionally, Oxford Biotherapeutics is developing antibody-based treatments for conditions such as acute myeloid leukemia and plans to integrate companion diagnostics into its programs to enhance disease management. Established in 2003, the company is based in Oxon, United Kingdom, with an operational site in San Jose, California, and maintains strategic collaborations with leading antibody-focused firms to broaden its therapeutic pipeline.

Anaxsys

Venture Round in 2007
Anaxsys Technology Ltd, established in 2002 and based in Send, UK, is a medical device company specializing in respiratory devices. It develops and markets products such as respiR8, a continuous respiratory rate counter that aids in early patient deterioration detection, and asthma monitoring systems. These devices target patient monitoring, screening, and diagnostics in areas like asthma, vital signs, sleep apnea, and lung cancer. The company, formerly known as Asthma Alert Limited, changed its name to Anaxsys Technology Ltd in 2006.

Michelson Diagnostics

Seed Round in 2007
Michelson Diagnostics is the developer and manufacturer of products based on Multi-Beam Optical Coherence Tomography (OCT), the uniquely powerful, innovative optical imaging technology that is capable of imaging living tissue microstructure at < 10 µm resolution,in real time, to depths of 1 mm or more.

Zysis

Venture Round in 2007
Zysis Limited is a pharmaceutical company focused on developing innovative therapies for central nervous system disorders to enhance the quality of life for individuals affected by these conditions. The company is currently advancing two primary treatments: a once-weekly oral tablet designed for psychotic conditions and as an adjunctive therapy for major depressive disorder, and a once-daily formulation aimed at addressing specialized anxiety disorders, including panic disorders and post-traumatic stress disorder. Through its research and development efforts, Zysis seeks to provide medical practitioners with effective therapeutic options that improve patient care and treatment outcomes.

Whelan Refining

Venture Round in 2006
Whelan Refining Ltd recycles waste oil to produce base oil - the base for all industrial and automotive lubricants. It re-refines 50,000 tonnes per annum of used oils to produce a high-quality group I base oil for sale to the lubricant manufacturing industry. Whelan Refining was founded in 2005 and is based in Stoke-on-Trent, UK.

David Holmes BMW

Private Equity Round in 2006
Sytner Group Limited operates as a new and used car dealership company.

Critical Pharmaceuticals

Venture Round in 2005
Critical Pharmaceuticals Limited is a biotechnology company based in Nottingham, United Kingdom, founded in 2002 by Professor Steve Howdle. The company specializes in developing innovative drug delivery technologies, including CriticalSorb for non-invasive nasal delivery and CriticalMix for sustained release injectable products. Its portfolio features several therapeutic products aimed at addressing significant medical needs, such as CP024, a nasal growth hormone for growth hormone deficiency, and CP046, a nasal formulation of teriparatide for osteoporosis treatment. Other products include an injectable human growth hormone and a sustained release formulation of Bevacizumab for age-related macular degeneration. Critical Pharmaceuticals employs unique methods, including the use of supercritical carbon dioxide to enhance drug encapsulation in regulatory-approved polymers. As of July 31, 2017, the company was placed under liquidation.

Monica Healthcare

Seed Round in 2005
Monica Healthcare, based in Nottingham, United Kingdom, is a manufacturer of advanced fetal monitoring devices aimed at improving obstetric care. Founded in 2005, the company specializes in innovative wearable technologies that utilize wireless systems to monitor maternal heart rate, fetal heart rate, and uterine activity. One of its key products is The Novii, a single-use wireless patch designed for both hospital and home use. Monica Healthcare's devices are intended to enhance the birth experience for midwives, labor and delivery nurses, and expectant mothers, while also facilitating access to obstetric services. In addition to its product offerings, the company provides training, repairs, and support services to its customers. Since 2017, Monica Healthcare has been operating as a subsidiary of GE Healthcare.

Ergomed

Venture Round in 2005
Ergomed plc is a UK-based company specializing in providing drug development services to the pharmaceutical and biotechnology industries. It operates through two primary segments: Clinical Research Services and Pharmacovigilance. The Clinical Research Services segment offers a range of clinical development services, catering to both major pharmaceutical companies and smaller drug developers. The Pharmacovigilance segment focuses on monitoring drug safety and providing medical information services. Additionally, Ergomed has a Co-Development Business, which involves partnerships with pharmaceutical and biotech companies to develop new drugs, allowing the company to earn revenue from milestones and product sales associated with these drug assets. Overall, Ergomed is dedicated to supporting the drug development process while ensuring safety and compliance within the healthcare sector.

Demon Tweeks

Acquisition in 2004
Demon Tweeks is a retailer specializing in high-performance equipment and accessories tailored for motorsport competitors, car tuners, and motorcycle enthusiasts. The company offers a wide range of motor parts and accessories, catering to the needs of those involved in motorsport and automotive customization. By focusing on quality and performance, Demon Tweeks has established itself as a key player in the automotive retail sector, providing products that enhance both vehicle performance and the overall driving experience.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.